AI in Pharmaceutical Formulation: A Comprehensive Review
DOI:
https://doi.org/10.65455/nshrsr55关键词:
AI, Pharmaceutical Formulation, Machine Learning, Intelligent Delivery Systems, Formulation Design, Process Control, Quality by Design, Formulation Informatics摘要
This review systematically evaluates the current status, application scenarios, and implementation effectiveness of artificial intelligence (AI) technologies in pharmaceutical formulation. It analyzes existing challenges and future directions to provide a technical reference for rational formulation development. Methods: We retrieved literature published between 2020 and 2025 from core databases including PubMed, MEDLINE, Embase, and Cochrane Library, focusing on high-quality studies applying AI to formulation design, optimization, production, and quality control. A systematic review methodology was employed to summarize technical approaches, performance metrics, and comparative outcomes between AI and traditional methods across various formulation types. Results: Analysis of 67 qualified studies revealed significant advantages of AI technologies across multiple formulation development stages. In drug delivery system design, AI-assisted nanocarrier development reduced development time by 60%-70% on average. For formulation optimization, AI models achieved 85%-93% accuracy in predicting critical quality attributes, representing a 25%-40% improvement over traditional empirical methods. In manufacturing processes, AI control strategies improved product batch consistency by 30%-50%. Furthermore, AI-driven adaptive learning frameworks demonstrated capability for continuous formulation and process optimization through real-time data integration. Conclusion: AI is fundamentally transforming pharmaceutical formulation development paradigms through data-driven approaches that significantly enhance efficiency, reduce costs, and improve product quality. Despite challenges in data quality, model interpretability, and industrial implementation, ongoing algorithm innovations and multidisciplinary integration are expected to advance pharmaceutical formulation into a new era of precision, personalization, and intelligence.参考
[1]BRANKE R., et al. Interpretability challenges of AI in regulated industries, Nature Machine Intelligence, 2022, 4(12):1054–1063.
[2]CHEN J., et al. AI in pharmaceutical development: Current status and future trajectory. Drug Discovery Today, 2023, 28(5):103567.
[3]FEI X, et al. AI-optimized lyophilization cycles for biopharmaceuticals. Journal of Pharmaceutical Sciences, 2023, 112(4): 1023–1034.
[4]GUPTA H, et al. Predicting tablet dissolution using machine learning approaches. International Journal of Pharmaceutics, 2022, 615: 121502.
[5]JOHNSON M, et al. Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery. Advanced Materials, 2025, 37(42): 2102391.
[6]KABOUDI N, et al. Bayesian optimization of gel formulations using neural networks. European Journal of Pharmaceutical Sciences, 2022, 178: 106282.
[7]LI Y, et al. Deep learning-based visual inspection of pharmaceutical injections. IEEE Transactions on Industrial Informatics, 2023, 19(2): 1567–1576.
[8] LIU M, et al. Interdisciplinary education for AI in pharmaceuticals. Nature Reviews Drug Discovery, 2023, 22(7): 535–536.
[9]MARQUES L, et al. Advancing precision medicine: a review of innovative in silico approaches for drug development. Pharmaceutics, 2024, 16(3): 332.
[10]MOHAMMED A A, et al. Regulatory frameworks for AI in drug development. Clinical Pharmacology & Therapeutics, 2023, 113(3): 491–499.
[11]NGARI K, et al. Physics-informed machine learning for pharmaceutical applications. Journal of Controlled Release, 2022, 352: 1034–1048.
[12]OUMA R B, et al. Reinforcement learning optimization of nanoparticle manufacturing. Chemical Engineering Journal, 2022, 435: 134856.
[13]REHMAN A V, et al. Generative adversarial networks for novel formulation design. Nature Machine Intelligence, 2023, 5(3): 234–247.
[14]SHARMA A. Economic challenges in pharmaceutical formulation development. Nature Reviews Drug Discovery, 2022, 21(3): 215–230.
[15]SHARMA P, et al. Talent gaps in AI-pharmaceutical integration. Nature Biotechnology, 2023, 41(4): 468–475.
[16]SINGH S, et al. Failure mode prediction in tablet manufacturing using AI. AIChE Journal, 2023, 69(4): e18045.
[17]SINGHAL S, et al. Data challenges in AI-driven pharmaceutical development. Drug Discovery Today, 2023, 28(1): 103398.
[18]SOFIAN A S, et al. Transfer learning for pharmaceutical process development. Computers & Chemical Engineering, 2023, 170: 108115.
[19]THOMPSON R, et al. Adaptive AI framework for pharmacokinetics using GATs, transformers, and AutoML. Molecular Diversity, 2025, 29(3): 1456–1472.
[20]WANG L, et al. Federated learning for pharmaceutical data collaboration. Science Advances, 2023, 9(24): eadg9556.
[21]WANG S, et al. Early insights into AI and machine learning applications in hydrogel microneedles: A short review. Micro, 2025, 5(4): 48.
[22]WU B, et al. LSTM-based prediction of cell culture parameters in bioreactors. Computers & Chemical Engineering, 2022, 161: 107761.
[23]YADAV J P, et al. AI-enhanced PBPK modeling for special populations. CPT: Pharmacometrics & Systems Pharmacology, 2023, 12(3): 312–325.
[24]YADAV S, et al. Gradient boosting for pharmaceutical stability prediction. International Journal of Pharmaceutics, 2022, 617: 121605.
